Angiogenesis, thrombogenesis, endothelial dysfunction and angiographic severity of coronary artery disease

被引:51
作者
Chung, NA [1 ]
Lydakis, C [1 ]
Belgore, F [1 ]
Li-Saw-Hee, FL [1 ]
Blann, AD [1 ]
Lip, GYH [1 ]
机构
[1] City Hosp, Univ Dept Med, Haemostasis Thrombosis & Vasc Biol Unit, Birmingham B18 7QH, W Midlands, England
关键词
D O I
10.1136/heart.89.12.1411
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Thrombogenesis, angiogenesis, and endothelial damage/dysfunction are components in the pathogenesis of atherosclerosis. Objective: To investigate the relation of these variables to atherosclerotic disease severity and the possible interrelations between the three. Methods: 111 patients attending for coronary angiography were studied ( 85 male, 26 female; mean (SD) age, 61.6 (10.0) years). Plasma concentrations of von Willebrand factor (vWf, a marker of endothelial damage/dysfunction), vascular endothelial growth factor (VEGF, associated with angiogenesis), soluble VEGF receptor Flt-1 (sFlt-1), and tissue factor (TF, a key component of coagulation) were measured by an enzyme linked immunosorbent assay. Following angiography, disease severity was assessed by the number of coronary vessels diseased (> 50% stenosis) and by a coronary atheroma score. Results: All indices were raised in the patients compared with 34 healthy controls except sFlt-1, which was lower in the patients. No significant correlations were found between the coronary atheroma score and values of vWf ( Spearman correlations: r = 0.21, p = 0.83), VEGF ( r = 0.11, p = 0.27), or TF ( r = 20.04, p = 0.68). However, there was an inverse correlation between plasma sFlt-1 and coronary atheroma score ( r = 20.19, p = 0.049). The number of vessels diseased had no relation to any marker. Correlations were found between TF and VEGF ( r = 0.25, p = 0.008) and between TF and sFlt-1 ( r = 0.42, p< 0.001) in the patients. Conclusions: Despite evidence of abnormal angiogenesis ( VEGF and sFlt-1), thrombogenesis ( TF), and endothelial damage/dysfunction ( vWf) in the patients with coronary artery disease, there was no correlation between VEGF, sFlt-1, vWf, or TF and angiographically defined disease severity.
引用
收藏
页码:1411 / 1415
页数:5
相关论文
共 37 条
[1]   Regulation of vascular endothelial growth factor production and angiogenesis by the cytoplasmic tail of tissue factor [J].
Abe, K ;
Shoji, M ;
Chen, J ;
Bierhaus, A ;
Danave, I ;
Micko, C ;
Casper, K ;
Dillehay, DL ;
Nawroth, PP ;
Rickles, FR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (15) :8663-8668
[2]  
Armesilla AL, 1999, MOL CELL BIOL, V19, P2032
[3]  
Austen W G, 1975, Circulation, V51, P5
[4]  
BATTEGAY EJ, 1995, J MOL MED, V73, P333
[5]  
Belgore F., 1999, Blood Coagulation and Fibrinolysis, V10, P536, DOI 10.1097/00001721-199912000-00026
[6]   Plasma levels of vascular endothelial growth factor and its soluble receptor (sFlt-1) in essential hypertension [J].
Belgore, FM ;
Blann, AD ;
Li-Saw-Hee, FL ;
Beevers, DG ;
Lip, GYH .
AMERICAN JOURNAL OF CARDIOLOGY, 2001, 87 (06) :805-+
[7]   Successful therapy reduces levels of vascular endothelial growth factor (VEGF) in patients with hypertension and patients with hypercholesterolemia [J].
Belgore, FM ;
Lip, GYH ;
Blann, AD .
ATHEROSCLEROSIS, 2000, 151 (02) :599-599
[8]   Measurement of free and complexed soluble vascular endothelial growth factor receptor, Flt-I, in fluid samples: development and application of two new immunoassays [J].
Belgore, FM ;
Blann, AD ;
Lip, GY .
CLINICAL SCIENCE, 2001, 100 (05) :567-575
[9]   The endothelium in atherothrombotic disease: assessment of function, mechanisms and clinical implications [J].
Blann, AD ;
Yip, GYH .
BLOOD COAGULATION & FIBRINOLYSIS, 1998, 9 (04) :297-306
[10]   A RELIABLE MARKER OF ENDOTHELIAL-CELL DYSFUNCTION - DOES IT EXIST [J].
BLANN, AD ;
TABERNER, DA .
BRITISH JOURNAL OF HAEMATOLOGY, 1995, 90 (02) :244-248